Better outcomes, better value

Change the outcome for your healthcare budgets

With the ever increasing economic constraints seen in many healthcare systems we understand that your therapy choice has to satisfy your budget as well.

By implementing a 2 week challenge assessment window when dealing with chronic wounds you will be able to quickly assess whether a treatment pathway is having a positive effect or whether to reassess the patient and look at other options. By implementing an assessment window you will avoid needlessly repeating expensive treatment that is not working.

International consensus documents state an antimicrobial dressing should have a positive effect on the wound and the patient within 2 weeks – why settle for anything less?15,16

Economic analysis of a clinical trial in chronic wounds demonstrates that although ACTICOAT was not the cheapest dressing used in the trial its use resulted in a lower cost of nursing time and an overall lower cost per healed wound compared to the other silver dressings assessed (Fig,1)17

ACTICOAT cost per healed wound comparison

Figure 1. In a comparative study in mixed chronic wounds (n=75) the total cost per healed wound was lower compared to the other silver dressings assessed17.

By providing the cost effective solution ACTICOAT enables you to be there for your patients and your budgets.

Change the outcome, take the ACTICOAT 2 WEEK CHALLENGE.

Apply to receive a 2 week's supply of ACTICOAT Flex* samples for appropriate use on an infected wound.

*Where possible samples will be ACTICOAT Flex, in areas where ACTICOAT Flex is not registered an alternative ACTICOAT variant may be offered.

™ All trademarks acknowledged

References

  1. Kelly J. Addressing the problem of increased antibiotic resistance. Prof Nurs 2001; 17(1): 56-9
  2. Hamilton-Miller JMT, Shah S, Smith C. Silver sulphadiazine: a comprehensive in-vitro reassessment. Chemotherapy 1993; 39: 405-9
  3. Maillard J-Y and Denyer SP. 2006. Focus on Silver. EWMA JournalV6(1)
  4. Warriner R and Burrell R. Infection and the chronic wound - a focus on silver. Advances in Skin and Wound Care Vol 18 (Supp. 1) Oct 2005
  5. Chopra I. (2007) The increasing use of silver based products as antimicrobial agents: a useful development or a cause of concern. Journal of Antimicrobial Chemotherapy 59, 587-590
  6. Vlachou E, et al. The safety of nanocrystalline silver dressings on burns: A study of systemic absorption. Burns 2007. 33(8):979-85
  7. Sibbald R G, Browne A C, Coutts P, Queen D, 'A Screening Evaluation of an Ionized Nanocrystalline Silver Dressing in Chronic Wound Care'. Ostomy Wound Management 2001; 47(10): 38-4
  8. Gago M, et al., A comparison of three silver-containing dressings in the treatment of infected, chronic wounds. Wounds 2008; 20 (10): 273-278
  9. Wright JB, et al. 'Wound Management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment', American Journal of Infection Control 1998; 26(6): 572-577 
  10. Smith & Nephew Data on File; 0810016 
  11. Smith & Nephew Data on File; 0810017 
  12. Hope R, et al., (2012) The in-vitro antibacterial activity of nanocrystalline silver dressings against bacteria withNDM-1 carbapenemase. Poster at EWMA, Austria, 2012. 
  13. Smith & Nephew Data on File WRP-TW141-022 
  14. Westain Report Ref: #971030
  15. World Union of Wound Healing Societies (WUWHS). Principles of best practice: Wound infection in clinical practice. An international consensus. London: MEP Ltd, 2008. Available from www.woundsinternational.com  
  16. International consensus. Appropriate use of silver dressings in wounds. An expert working group consensus. London: Wounds International, 2012.Available from:www.woundsinternational.com 
  17. Searle and Bielby (2010) Dressing strategies for the management of infected wounds in community wound care: impacts and implications. Poster at Wounds UK, Harrogate Nov 2010.
  18. Murray, S and Pardoe, A (2010) Making an Impact: Improving the patient experience using ACTICOAT Flex. Case Study Booklet 
  19. Tongue G., Prytherch J., Harvey A. The Silver Revolution. Exeter Primary Care Trust. Poster Presentation. Wounds UK. Harrogate 2004 
  20. Bowering K. “ACTICOAT Moisture Control. A New Clinical Option” Case study presentation. Satellite Symposium at Stuttgart (a joint meeting for ETRS, EWMA and DGfW) 2005

Infected Wounds

Change
the outcome